Application 217193
- Type
- ANDA
- Sponsor
- INVAGEN PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LANREOTIDE ACETATE | LANREOTIDE ACETATE | SOLUTION;SUBCUTANEOUS | EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML) | No | No |
| 002 | LANREOTIDE ACETATE | LANREOTIDE ACETATE | SOLUTION;SUBCUTANEOUS | EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML) | No | No |
| 003 | LANREOTIDE ACETATE | LANREOTIDE ACETATE | SOLUTION;SUBCUTANEOUS | EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML) | No | No |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 78843 | ORIG | 2024-06-20 |